Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
Nicholas P. Semenkovich, Jeffrey J. Szymanski, Noah Earland, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006284-e006284
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Ronan J. Kelly, Blair V. Landon, Ali H. Zaidi, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 1023-1034
Open Access | Times Cited: 31
ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer
Aakash Desai, Tadana A. Vázquez, Keishla M. Arce, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 940-940
Open Access | Times Cited: 12
Circulating Tumor Cells and DNA in Early Diagnosis and Prognosis of Metastatic Cancer
Marium Jahan, A. Rubab, Mohsin Ali, et al.
IntechOpen eBooks (2025)
Closed Access | Times Cited: 1
Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications
Danielle Benedict Sacdalan, Sami Ul Haq, Benjamin H. Lok
Current Oncology (2024) Vol. 31, Iss. 1, pp. 482-500
Open Access | Times Cited: 7
Surpassing sensitivity limits in liquid biopsy
Tina Moser, Ellen Heitzer
Science (2024) Vol. 383, Iss. 6680, pp. 260-261
Closed Access | Times Cited: 7
Unlocking the Next Frontier in Precision Oncology: Addressing Drug-Tolerant Residual Disease
W. Marston Linehan, Justin F. Gainor, Vincent K. Lam, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 915-919
Closed Access | Times Cited: 7
Harnessing ctDNA in Advanced Melanoma: A Promising Tool for Informed Clinical Decisions
Rugilė Pikturnienė, Alvydas Česas, Sonata Jarmalaitė, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1197-1197
Open Access | Times Cited: 6
The Method of Minimal Residual Disease Detection With Circulating Tumor DNA and Its Clinical Applications in Colorectal Cancer
Ming Liu, Tianhao Mu, Jia Gu, et al.
Cancer Reports (2025) Vol. 8, Iss. 3
Open Access
Liquid biopsies in cancer
Hang Yin, Manjie Zhang, Yu Zhang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Circulating tumor DNA in colorectal cancer: biology, methods and applications
Han Chen, Yang An, Chentong Wang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Plasma-First Testing in Advanced Lung Cancer: Evidence and Implications
Kaushal Parikh, Ayisha Hashmi, Pradeep S. Chauhan, et al.
Journal of Thoracic Oncology (2025) Vol. 20, Iss. 4, pp. 411-414
Closed Access
Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer
Chiara Reina, Berina Šabanović, Chiara Lazzari, et al.
Translational research (2024) Vol. 272, pp. 41-53
Closed Access | Times Cited: 4
High sensitivity ctDNA assays in genitourinary malignancies: current evidence and future directions
Kartik R. Patel, Soroush Rais‐Bahrami, Arnab Basu
The Oncologist (2024) Vol. 29, Iss. 9, pp. 731-737
Open Access | Times Cited: 4
A combination of hepatic leukemia factor and circulating tumor cells serve as effective biomarkers for lung adenocarcinoma prognosis
Yaofeng Zhi, Jinhua Wu, Ronggang Li, et al.
PeerJ (2025) Vol. 13, pp. e19092-e19092
Open Access
Clinical data mining: challenges, opportunities, and recommendations for translational applications
Huimin Qiao, Yijing Chen, Changshun Qian, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Plasma circulating tumor DNA unveils the efficacy of PD-1 inhibitors and chemotherapy in advanced gastric cancer
Rongqi Jiang, Cheng Xu, Ping Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization
Abel J. Bronkhorst, Stefan Holdenrieder
Medizinische Genetik (2023) Vol. 35, Iss. 4, pp. 201-235
Open Access | Times Cited: 8
Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges
Qin Dang, Lulu Zuo, Xinru Hu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 14
Open Access | Times Cited: 2
Flow cytometry in acute myeloid leukemia and detection of minimal residual disease
Qihui Cai, Haiqiang Lan, Yi Deng, et al.
Clinica Chimica Acta (2024) Vol. 564, pp. 119945-119945
Open Access | Times Cited: 2
Plasma ctDNA as a treatment response biomarker in metastatic cancers: evaluation by the RECIST working group
Alexander W. Wyatt, Saskia Litière, François‐Clément Bidard, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 22, pp. 5034-5041
Closed Access | Times Cited: 2
Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer
Noah Earland, Nicholas P. Semenkovich, Ricardo J. Ramirez, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 7, pp. 1409-1421
Open Access | Times Cited: 6
Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction
Xinxing Li, Tao Liu, Antonella Bacchiocchi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages
Brittany McKelvey, Hillary S. Andrews, Frederick L. Baehner, et al.
Diagnostics (2024) Vol. 14, Iss. 9, pp. 912-912
Open Access | Times Cited: 1
Liquid profiling for patients with advanced cancer is ready for clinical integration
Samantha O. Hasenleithner, Ellen Heitzer
memo - Magazine of European Medical Oncology (2024) Vol. 17, Iss. 3, pp. 182-189
Open Access | Times Cited: 1
Circulating tumor DNA (ctDNA) application in investigation of cancer: Bench to bedside
Hashem O. Alsaab, Mohammad S. Alzahrani, Ammar Abdulraheem Bahauddin, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 758, pp. 110066-110066
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top